IDXX

IDEXX Laboratories, Inc.
$556.93
+11.07 (+2.03%)
Mkt Cap 43.93B
Volume 485,784
52W Range 518.55-769.98
Sector Healthcare
Beta 1.54
EPS (TTM) 14.24 USD
P/E Ratio 39.11
Revenue (TTM) 4.55B USD
Rev Growth (5Y) +9.7%
EPS Growth (5Y) +14.1%
AlphaVal · Fair Value
What we estimate one share is worth
$254.96
Overvalued strong signal
118.4% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
A
Platform & Compounding FCF
88.8 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 4.30B 3.90B 3.66B 3.37B 3.22B 2.71B 2.41B 2.21B 1.97B 1.78B 1.60B 1.49B
Net Income 1.06B 887.87M 845.04M 679.09M 744.85M 581.78M 427.72M 377.03M 263.14M 222.04M 192.08M 181.91M
EPS 13.17 10.77 10.17 8.12 8.74 6.82 4.97 4.34 3.00 2.47 2.07 1.82
Free Cash Flow 1.05B 798.08M 772.88M 394.15M 636.00M 540.44M 303.93M 277.15M 296.57M 269.78M 133.44M 175.15M
FCF / Share 13.15 9.68 9.30 4.71 7.46 6.33 3.53 3.19 3.38 3.01 1.44 1.75
Operating CF 1.18B 929.00M 906.51M 542.98M 755.55M 648.06M 459.16M 400.08M 373.28M 334.57M 216.36M 235.85M
Total Assets 3.35B 3.29B 3.26B 2.75B 2.44B 2.29B 1.83B 1.54B 1.71B 1.53B 1.47B 1.38B
Total Debt 1.08B 986.95M 1.07B 1.47B 1.03B 1.00B 1.07B 1.00B 1.26B 1.20B 1.17B 899.00M
Cash & Equiv 180.07M 288.27M 453.93M 112.55M 144.45M 383.93M 90.33M 123.79M 187.68M 154.90M 128.99M 322.54M
Book Value 1.61B 1.60B 1.48B 608.74M 689.99M 632.09M 177.47M (9.51M) (54.11M) (108.35M) (84.12M) 117.52M
Return on Equity 0.66 0.56 0.57 1.12 1.08 0.92 2.41 N/A N/A N/A N/A 1.55
IDXX News
Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?
Aug 21, 2026 06:56 AM · zacks.com
IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve
Aug 20, 2026 08:41 AM · zacks.com
Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?
Aug 19, 2026 07:10 AM · zacks.com
IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day Transcript
Aug 18, 2026 01:41 PM · seekingalpha.com
IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests
Aug 14, 2026 10:03 AM · marketbeat.com
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock
Aug 12, 2026 06:46 AM · zacks.com
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
Aug 11, 2026 03:00 AM · businesswire.com
IDEXX Laboratories: Worth The Premium
Aug 08, 2026 04:00 AM · seekingalpha.com
Aurora Investment Managers LLC. Makes New Investment in IDEXX Laboratories, Inc. $IDXX
Aug 08, 2026 12:03 AM · defenseworld.net
Here is Why Growth Investors Should Buy Idexx (IDXX) Now
Aug 06, 2026 09:46 AM · zacks.com